1. Home
  2. ATAI vs ISD Comparison

ATAI vs ISD Comparison

Compare ATAI & ISD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • ISD
  • Stock Information
  • Founded
  • ATAI 2018
  • ISD 2012
  • Country
  • ATAI Germany
  • ISD United States
  • Employees
  • ATAI N/A
  • ISD N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • ISD Trusts Except Educational Religious and Charitable
  • Sector
  • ATAI Health Care
  • ISD Finance
  • Exchange
  • ATAI Nasdaq
  • ISD Nasdaq
  • Market Cap
  • ATAI 444.7M
  • ISD 472.3M
  • IPO Year
  • ATAI 2021
  • ISD N/A
  • Fundamental
  • Price
  • ATAI $4.72
  • ISD $14.68
  • Analyst Decision
  • ATAI Strong Buy
  • ISD
  • Analyst Count
  • ATAI 3
  • ISD 0
  • Target Price
  • ATAI $13.33
  • ISD N/A
  • AVG Volume (30 Days)
  • ATAI 4.8M
  • ISD 127.1K
  • Earning Date
  • ATAI 11-12-2025
  • ISD 01-01-0001
  • Dividend Yield
  • ATAI N/A
  • ISD 9.69%
  • EPS Growth
  • ATAI N/A
  • ISD N/A
  • EPS
  • ATAI N/A
  • ISD N/A
  • Revenue
  • ATAI $2,309,000.00
  • ISD N/A
  • Revenue This Year
  • ATAI $712.99
  • ISD N/A
  • Revenue Next Year
  • ATAI N/A
  • ISD N/A
  • P/E Ratio
  • ATAI N/A
  • ISD N/A
  • Revenue Growth
  • ATAI 510.85
  • ISD N/A
  • 52 Week Low
  • ATAI $1.03
  • ISD $10.98
  • 52 Week High
  • ATAI $5.34
  • ISD $13.17
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 61.12
  • ISD 63.10
  • Support Level
  • ATAI $4.50
  • ISD $14.44
  • Resistance Level
  • ATAI $4.75
  • ISD $14.67
  • Average True Range (ATR)
  • ATAI 0.28
  • ISD 0.08
  • MACD
  • ATAI -0.04
  • ISD 0.00
  • Stochastic Oscillator
  • ATAI 59.28
  • ISD 94.04

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About ISD PGIM High Yield Bond Fund Inc.

PGIM High Yield Fund Inc is a diversified, closed-end management investment company, active in the financial services domain. The Fund's investment objective is to provide a high level of current income. It invests at least 80% of its investable assets in a diversified portfolio of high-yield fixed-income instruments that are rated below investment grade with varying maturities and other investments.

Share on Social Networks: